Randomized, Single Center Study About the Impact of an E-learning Dedicated to Myocardial Infarction Patient
Primary Purpose
Acute Myocardial Infarction
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
E-learning
Sponsored by
About this trial
This is an interventional supportive care trial for Acute Myocardial Infarction focused on measuring e-learning, drug adherence, health literacy
Eligibility Criteria
Inclusion Criteria:
- Admission for acute coronary syndrome (ACS) in the cardiology unit of the University hospital of Lausanne (NSTEMI or STEMI)
- Have a percutaneous coronary intervention (PCI) as therapeutic strategy
- Patients going through an elective PCI for a second vessel after having suffered from an acute coronary syndrome in the previous month
- > 18 years
- Total discernment capacity and French speaking
- Have a digital tablet, a smartphone or a computer to have the possibility to watch the e-learning at home
- Informed Consent as documented by signature (Appendix Informed Consent Form)
Exclusion Criteria:
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
- Refugee claimants, homeless persons, prisoners by impossibility to contact them after discharge
- Patients with communication problems
- Life expectancy < 6 months caused by other co-morbidities
Sites / Locations
- Centre Hsopitalier Universitaire Vaudois
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
BASIC
Control
Arm Description
"mon cœur, mon BASIC" video viewing and installation in the own smartphone or tablet of the patient
Usual care
Outcomes
Primary Outcome Measures
ARMS (Adherence to Refill and Medication Score) score difference
Adherence to Refill and Medication Score is a self-reported questionnaire with 12-items. 8 items assess adherence to taking medications, and 4 items assess the refill to medication. The results can vary from 12 (most adherent) to 48 (less adherent). The ARMS questionnaire will be assessed after 1 month, 3 months and 6 months. We will assess the difference in the mean ARMS score between control group and intervention group at these 3 timepoints.
Secondary Outcome Measures
Knowledge about the disease and medications
Difference in a knowledge score assessed with a 9 multiple choice questions about the disease (examples: what is a coronary artery? What happens during an acute myocardial infarction? Which medication is used to reduce cholesterol level?). The maximum score is 9 and the minimum is 0. The mean score will be tested between intervention and control group. The score variation will be assessed during time after ACS.
LDL-c measurement
Difference in LDL-c measurements from discharge to 3 months
BMI
Difference in BMI from discharge to 6 months
Target Blood Pressure
proportion of patients being in the target blood pressure measurements at 6 months
composite endpoint of readmission, reinfarction or emergency visit
Readmissions, reinfarction and emergency visit will be assessed with a questionnaire at 6 months. We will assess if there is a difference between intervention and control group.
Full Information
NCT ID
NCT03949608
First Posted
April 25, 2019
Last Updated
September 24, 2020
Sponsor
University of Lausanne Hospitals
1. Study Identification
Unique Protocol Identification Number
NCT03949608
Brief Title
Randomized, Single Center Study About the Impact of an E-learning Dedicated to Myocardial Infarction Patient
Official Title
Randomized, Single Center Study About the Impact of an E-learning Dedicated to Myocardial Infarction Patient
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
February 4, 2019 (Actual)
Primary Completion Date
March 22, 2020 (Actual)
Study Completion Date
July 15, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Lausanne Hospitals
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Acute coronary syndrome (ACS) is still one of the major cause of morbi-mortality in Europe. After an ACS, patients should be treated with secondary prevention medication to reduce the risk of recurrence. However, it is known that patients do not take all their medicines as expected, which leads to readmission at the hospital. To enhance drug adherence, the investigators sought to develop an interactive e-learning tool for these patients. This e-learning includes information about the disease, the acute care and the subsequent medications being prescribed. The tool is now ready to use and the investigators want to assess if it has the impact to enhance self-care management of ACS patients.
Detailed Description
Cardiovascular disease is a major cause of morbi-mortality in industrialized countries. Risk of recurrence after appropriate treatment is particularly frequent in patients with inadequate observance. Secondary prevention is therefore essential to reduce the morbi-mortality of high-risk cardiovascular patients. Risk factor control and lifestyle interventions are important for these high-risk patients to reduce the overall incidence of cardiac disease. To treat these risk factors and for secondary prevention after a cardiovascular event, some medications have been shown to be efficient and European guidelines have been written to enhance evidence-based medicine prescriptions for STEMI and NSTEMI. Despite this, concerns have been postulated about patient's self-adherence to these treatments. A study has shown a long-term adherence to medications of 71% for Aspirin, 46% for β-blockers and 44% for Lipid-lowering therapy for Coronary Artery Disease (CAD) patients. Non-adherence has been associated with increased morbi-mortality in this population.
Therefore, a variety of interventions was identified to enhance patient adherence to medication in the cardiovascular field. These strategies included:
Informational intervention (mailed information)
Sending reminder postcards, illustrated daily medication schedule distribution
Counseling on the importance of adherence to their cardiovascular medication and review of each medication during the hospital stay
Clinical pharmacist intervention with medication reconciliation, medication education, facilitation of the delivery of discharge medications, and post-discharge telephone call within 48-72h These interventions showed an impact on long-term medication adherence and health literacy, which could lead to an improvement of the morbi-mortality of cardiovascular risk patients.
In a previous study conducted at the University hospital of Lausanne, the investigators showed a very high prescription rate of guidelines-recommended medications for patients involved in the CHUV STEMI (ST-Elevation Myocardial Infarction) network. Therefore, the next step to reduce the morbi-mortality of high-risk cardiovascular patients is to enhance patient adherence to the cardiovascular drug regimen. Patient education is known as an effective process to enhance drug adherence. Unfortunately, patient education is difficult to implement because of it costs and for the time needed to educate the patient. The investigator's aim at testing a new approach using an e-learning tool for patient education purpose. The e-learning will be interactive and easy to use. It will inform the patient about his heart disease (acute coronary syndrome) and about his medications in a short time.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Myocardial Infarction
Keywords
e-learning, drug adherence, health literacy
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
We will randomize patients by block of 2 weeks of inclusion in intervention or controlled group. Each 2 weeks, all participants will be included in the intervention group, and the next 2 weeks the participants will be included in the control group
Masking
None (Open Label)
Allocation
Randomized
Enrollment
67 (Actual)
8. Arms, Groups, and Interventions
Arm Title
BASIC
Arm Type
Experimental
Arm Description
"mon cœur, mon BASIC" video viewing and installation in the own smartphone or tablet of the patient
Arm Title
Control
Arm Type
No Intervention
Arm Description
Usual care
Intervention Type
Other
Intervention Name(s)
E-learning
Intervention Description
The intervention consists of the presentation and installation of an internet tool to educate the patient about his heart condition and about his medications in addition to usual care. The tool is an interactive web-hosting video called "Mon Coeur, mon BASIC" adaptable to smartphones and tablets. The total length of the video is around 15 minutes. The e-learning is interactive because of the possibility to click in the video to have more details about a particular point. The tool includes a part about the heart and particularly about the ACS (physiopathology, diagnosis, coronarography, angioplasty). A second part includes an education about the medications prescribed. The patient will select the medication being prescribed and receive information about it.
Primary Outcome Measure Information:
Title
ARMS (Adherence to Refill and Medication Score) score difference
Description
Adherence to Refill and Medication Score is a self-reported questionnaire with 12-items. 8 items assess adherence to taking medications, and 4 items assess the refill to medication. The results can vary from 12 (most adherent) to 48 (less adherent). The ARMS questionnaire will be assessed after 1 month, 3 months and 6 months. We will assess the difference in the mean ARMS score between control group and intervention group at these 3 timepoints.
Time Frame
1,3 and 6 months
Secondary Outcome Measure Information:
Title
Knowledge about the disease and medications
Description
Difference in a knowledge score assessed with a 9 multiple choice questions about the disease (examples: what is a coronary artery? What happens during an acute myocardial infarction? Which medication is used to reduce cholesterol level?). The maximum score is 9 and the minimum is 0. The mean score will be tested between intervention and control group. The score variation will be assessed during time after ACS.
Time Frame
at time of inclusion, 1 day after inclusion for control group and after the viewing of the video for the intervention group, 1 month, 3 months and 6 months
Title
LDL-c measurement
Description
Difference in LDL-c measurements from discharge to 3 months
Time Frame
3 months
Title
BMI
Description
Difference in BMI from discharge to 6 months
Time Frame
6 months
Title
Target Blood Pressure
Description
proportion of patients being in the target blood pressure measurements at 6 months
Time Frame
6 months
Title
composite endpoint of readmission, reinfarction or emergency visit
Description
Readmissions, reinfarction and emergency visit will be assessed with a questionnaire at 6 months. We will assess if there is a difference between intervention and control group.
Time Frame
6 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Admission for acute coronary syndrome (ACS) in the cardiology unit of the University hospital of Lausanne (NSTEMI or STEMI)
Have a percutaneous coronary intervention (PCI) as therapeutic strategy
Patients going through an elective PCI for a second vessel after having suffered from an acute coronary syndrome in the previous month
> 18 years
Total discernment capacity and French speaking
Have a digital tablet, a smartphone or a computer to have the possibility to watch the e-learning at home
Informed Consent as documented by signature (Appendix Informed Consent Form)
Exclusion Criteria:
Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,
Refugee claimants, homeless persons, prisoners by impossibility to contact them after discharge
Patients with communication problems
Life expectancy < 6 months caused by other co-morbidities
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christel Bruggmann, PharmD
Organizational Affiliation
Centre Hospitalier Universitaire Vaudois (CHUV)
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hsopitalier Universitaire Vaudois
City
Lausanne
ZIP/Postal Code
1011
Country
Switzerland
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
34459744
Citation
Bruggmann C, Adjedj J, Sardy S, Muller O, Voirol P, Sadeghipour F. Effects of the Interactive Web-Based Video "Mon Coeur, Mon BASIC" on Drug Adherence of Patients With Myocardial Infarction: Randomized Controlled Trial. J Med Internet Res. 2021 Aug 30;23(8):e21938. doi: 10.2196/21938.
Results Reference
derived
Learn more about this trial
Randomized, Single Center Study About the Impact of an E-learning Dedicated to Myocardial Infarction Patient
We'll reach out to this number within 24 hrs